Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications

Hepatology

Volumn 28, Issue 6, 1998, Pages 1449-1453

  Beuers, Ulrich ^a   Boyer, James L ^b   Paumgartner, Gustav ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; URSODEOXYCHOLIC ACID;

BILE DUCT; BILIARY CIRRHOSIS; CHOLESTASIS; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HUMAN; LIVER PROTECTION; LIVER TOXICITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031770301     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280601     Document Type: Review

References (15)

1. Leuschner U, Leuschner M, Sieratzki J, Kurtz W, Hubner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci 1985;30:642-649.
2. Poupon R, Poupon RE, Calmus Y, Chretien Y, Ballet F, Darnis H Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987;1:834-836.
3. Leuschner U, Fischer H, Kurtz W, Güldütuna S, Hubner K, Hellstern A, Gatzen M, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989;97:1268-1274.
4. Mijayi K, Akiyama T, Ito M, Urakawa T, Shimaji Y. The effect of ursodeoxycholic acid on liver functions in patients with chronic liver disease. A double blind study in one institution and the study on the effect on hepatic blood flow. Rinsho to Kenkyu 1976;53:1395-1403.
5. Yamanaka M, Oto M, Obata H, Shimizu M, Sugata F, Hatta Y, Dohi Y, et al. The examination of the therapeutic efficacy of ursodeoxycholic acid on chronic hepatitis. A double blind study. Shindan to Chiryo 1976;64:2150-2157.
6. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.
7. Shoda M. Über die Ursodesoxycholsäure aus Bärengallen und ihre physiologische Wirkung. J Biochem 1927;7:505-510.
8. Kitani K. Hepatoprotective effect of ursodeoxycholate in experimental animals. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies For the Treatment of Hepatobiliary Diseases. Lancaster: Kluwer, 1990;43-56.
9. Hofmann AE Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol 1994;204(Suppl):1-15.
10. Stiehl A, Raedsch R, Rudolph G. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 1990;98:424-428.
11. Marteau P, Chazouilleres O, Myara A, Jian R, Rambaud JC, Poupon R. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. HEPATOLOGY 1990;12:1206-1208.
12. Eusufzai S, Ericsson S, Cederlund T, Einarsson K, Angelin B. Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test. Gut 1991;32:1044-1048.
13. Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Effect of ursodeoxycholic acid on kinetics of major hydrophobic bile acids in health and in chronic cholestatic liver disease. HEPATOLOGY 1992;15:603-608.
14. Rudolph G, Endele R, Senn M, Stiehl A. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. HEPATOLOGY 1993;17:1028-1032.
15. Mazzella G, Parini P, Bazzoli F, Villanova N, Festi D, Aldini R, Roda A, et al. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis. Dig Dis Sci 1993;38:896-902.